Union Bancaire Privee UBP SA Sells 6,405 Shares of Intuitive Surgical, Inc. $ISRG

Union Bancaire Privee UBP SA reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.6% in the 3rd quarter, HoldingsChannel reports. The firm owned 17,630 shares of the medical equipment provider’s stock after selling 6,405 shares during the period. Union Bancaire Privee UBP SA’s holdings in Intuitive Surgical were worth $7,885,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Oak Thistle LLC bought a new stake in Intuitive Surgical during the third quarter worth about $619,000. Heartwood Wealth Advisors LLC bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $110,000. Venture Visionary Partners LLC boosted its holdings in shares of Intuitive Surgical by 12.4% in the 3rd quarter. Venture Visionary Partners LLC now owns 5,088 shares of the medical equipment provider’s stock worth $2,276,000 after acquiring an additional 562 shares in the last quarter. Red Spruce Capital LLC acquired a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $229,000. Finally, HCR Wealth Advisors grew its position in Intuitive Surgical by 23.9% during the 3rd quarter. HCR Wealth Advisors now owns 1,558 shares of the medical equipment provider’s stock worth $690,000 after acquiring an additional 301 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.9%

Intuitive Surgical stock opened at $554.58 on Wednesday. The stock has a market cap of $198.81 billion, a price-to-earnings ratio of 73.36, a P/E/G ratio of 5.14 and a beta of 1.68. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The business’s 50-day simple moving average is $534.09 and its 200 day simple moving average is $505.41.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 114,007 shares of company stock valued at $63,533,844 over the last three months. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. Royal Bank Of Canada lifted their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday. BTIG Research raised their target price on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $609.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.